Account-creators
179
edits
(split out) |
(→General: added a sentence about oncocytic type) |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
'''Intraductal papillary mucinous tumour''', abbreviated '''IPMT''', is an uncommon tumour of the [[pancreas]]. | '''Intraductal papillary mucinous tumour''', abbreviated '''IPMT''', is an uncommon tumour of the [[pancreas]]. | ||
It is also known as '''intraductal papillary mucinous neoplasm''' (abbreviated '''IPMN'''). | |||
==General== | ==General== | ||
Line 8: | Line 10: | ||
***Main duct (bad prognosis). | ***Main duct (bad prognosis). | ||
***Branch (good prognosis). | ***Branch (good prognosis). | ||
Clinical: | Clinical: | ||
Line 28: | Line 31: | ||
#*Less commonly associated with invasive carcinoma. | #*Less commonly associated with invasive carcinoma. | ||
The oncocytic subtype of IPMT is now known to be genetically separate from other types.<ref name=pmid27282351>{{cite journal |author=Basturk O, Tan M, Bhanot U, Allen P, Adsay V, Scott SN, Shah R, Berger MF, Askan G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Sigel C, Iacobuzio-Donahue C, Klimstra DS. |title=The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes |journal=Mod Pathol |volume=29 |pages=1058-69 |year=2016 |pmid=27282351 }}</ref> | |||
=====Behaviour===== | =====Behaviour===== | ||
*Adenoma. | *Adenoma. |